Final EMA oracle [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2010-02-01 13:28 (5570 d 20:31 ago) – Posting: # 4674
Views: 24,060

Dear D Labes!

❝ Section 4.1.8 Evaluation

Subject accountability

❝ "In studies with more than two treatment arms ..."


Yes, ‘discovered’ this piece in the meantime also…

❝ Do they claim that such studies should evaluated as if they consist of a series of classical 2×2 cross-over's? ("Extraction of 2×2 comparisons" in Helmut's famous lectures)


I can’t believe that. I would guess that one should only omit information on the 'foreign' reference as far as possible (descriptive statistics, plots, etc.).

The section mentioning the 4-way fed/fasted study is a mystery to me.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,667 registered users;
73 visitors (0 registered, 73 guests [including 11 identified bots]).
Forum time: 11:00 CEST (Europe/Vienna)

Patients may recover in spite of drugs or because of them.    John Gaddum

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5